omeprazole has been researched along with Anisakiasis in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Anisakiasis: Infection with roundworms of the genus ANISAKIS. Human infection results from the consumption of fish harboring roundworm larvae. The worms may cause acute NAUSEA; VOMITING; or penetrate into the wall of the DIGESTIVE TRACT where they give rise to EOSINOPHILIC GRANULOMA in the STOMACH; INTESTINES; or the OMENTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluates the effectiveness of gastric acid secretion inhibitors (omeprazole and ranitidine), gastric mucosal protectants (sucralfate) and anthelmintics (mebendazole and flubendazole) in treating anisakiasis in Wistar rats." | 4.02 | Acute Anisakiasis: Pharmacological Evaluation of Various Drugs in an Animal Model. ( Arrebola, F; Gómez-Mateos, M; González, JM; Navarro, MC; Romero, MC; Valero, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gómez-Mateos, M | 1 |
| Arrebola, F | 1 |
| Navarro, MC | 1 |
| Romero, MC | 1 |
| González, JM | 1 |
| Valero, A | 1 |
1 other study available for omeprazole and Anisakiasis
| Article | Year |
|---|---|
Acute Anisakiasis: Pharmacological Evaluation of Various Drugs in an Animal Model.
Topics: Acute Disease; Animals; Anisakiasis; Anthelmintics; Anti-Ulcer Agents; Antinematodal Agents; Disease | 2021 |